Novartis AG (NVS)
149.08
+1.00
(+0.68%)
USD |
NYSE |
May 18, 15:40
Novartis EPS Diluted (Quarterly) : 1.654 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Roche Holding AG | -- |
| AstraZeneca PLC | 0.9849 |
| GSK Plc | 1.149 |
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.169B |
| Revenue (Quarterly) | 13.17B |
| Total Expenses (Quarterly) | 9.997B |
| Enterprise Value | 322.99B |
| Gross Profit Margin (Quarterly) | 73.78% |
| Profit Margin (Quarterly) | 24.07% |
| Earnings Yield | 4.71% |
| Operating Earnings Yield | 5.62% |
| Normalized Earnings Yield | 4.949 |